Antipsychotic drug-like facilitation of latent inhibition by a brain-penetrating neurotensin-1 receptor agonist

Peripherally administered oxytocin modulates latent inhibition in a manner consistent with antipsychotic drugs

(2015) D. Feifel et al.   BEHAVIOURAL BRAIN RESEARCH

Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: Assessing for tolerance and cross-tolerance to clozapine

(2015) Shinnyi Chou et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients

(2014) Andrea Jobst et al.   ACTA NEUROPSYCHIATRICA

Systemic administration of the neurotensin NTS₁-receptor agonist PD149163 improves performance on a memory task in naturally deficient male Brown Norway rats.

(2014) Ashley A. Keiser et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Reduced Levels of Vasopressin and Reduced Behavioral Modulation of Oxytocin in Psychotic Disorders

(2014) Leah H. Rubin et al.   SCHIZOPHRENIA BULLETIN

Effects of group II and III metabotropic glutamate receptor ligands on conditioned taste aversion learning

(2013) D. Klakotskaia et al.   BEHAVIOURAL BRAIN RESEARCH

Assessment of attention in male and female Brattleboro rats using a self-paced five-choice serial reaction time task

(2013) Michael D. Berquist II et al.   BRAIN RESEARCH

Hypothalamic Neurotensin Projections Promote Reward by Enhancing Glutamate Transmission in the VTA

(2013) K. A. Kempadoo et al.   JOURNAL OF NEUROSCIENCE

NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain

(2012) Kristin E. Smith et al.   BEHAVIOURAL BRAIN RESEARCH

Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats.

(2011) David Feifel et al.   BEHAVIORAL NEUROSCIENCE

The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats

(2011) Elizabeth N. Holly et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Modeling psychotic and cognitive symptoms of affective disorders: Disrupted latent inhibition and reversal learning deficits in highly stress reactive mice

(2010) A. Knapman et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment

(2009) Ina Weiner et al.   BEHAVIOURAL BRAIN RESEARCH

Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance

(2009) Siobhan Briody et al.   BEHAVIOURAL BRAIN RESEARCH

The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex

(2009) Zhimin Li et al.   BRAIN RESEARCH

Metabotropic glutamate receptor 5 in conditioned taste aversion learning

(2009) A. Simonyi et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature

(2009) David Feifel et al.   NEUROPHARMACOLOGY

The Brattleboro Rat Displays a Natural Deficit in Social Discrimination That Is Restored by Clozapine and A Neurotensin Analog

(2009) D Feifel et al.   NEUROPSYCHOPHARMACOLOGY

Role of neurotensin receptor 1 in the regulation of food intake by neuromedins and neuromedin-related peptides

(2009) Eun Ran Kim et al.   NEUROSCIENCE LETTERS

The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle

(2008) P SHILLING et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Molecular Mechanisms of Antidiuretic Effect of Oxytocin

(2007) C. Li et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY